FDA clears Interpore's GEO spinal implant:
This article was originally published in Clinica
Interpore Cross International has received US FDA 510(k) clearance to market its GEO Structure implant for use in a variety of applications in the lumbar and thoracic regions of the spine. The device is designed to restore the biomechanical integrity of the anterior, middle and posterior spinal column, even in the absence of fusion for a prolonged period, says the Irvine, California firm.
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.